Study guide

12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae

Key Takeaways Explain This Topic AI

Antepartum haemorrhage (APH) is defined as bleeding from or into the genital tract after 28 completed weeks of pregnancy prior to delivery.

Placenta Previa presents with painless, causeless, recurrent bright red vaginal bleeding; digital vaginal examination is strictly contraindicated due to risk of fatal hemorrhage.

Abruptio Placentae presents with painful, dark red bleeding, a woody hard tender uterus, high association with maternal hypertension, and risk of Couvelaire uterus and DIC.

Transvaginal ultrasonography is the gold standard for diagnosing placenta previa, while Macafee and Johnson protocol guides conservative management in preterm stable cases.

Vasa Previa is characterized by the triad of membrane rupture, painless vaginal bleeding, and fetal bradycardia, diagnosed using the Apt (NaOH) test.

Last updated: July 2026

12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae

Antepartum Haemorrhage (APH) is defined as bleeding from or into the genital tract after 28 completed weeks of gestation (the threshold of fetal viability in India) up to the time of delivery of the fetus. APH affects 3–5% of all pregnancies and demands rapid clinical diagnosis and targeted intervention to prevent maternal hemorrhagic shock and fetal demise.

1. Classification & Etiology of APH

Major causes of antepartum hemorrhage are categorized into:

Placenta Previa (~35%): Bleeding due to placental implantation in the lower uterine segment.

Abruptio Placentae (~30%): Premature separation of a normally implanted placenta.

Extraplacental Causes (~5%): Cervical lesions (ectropion, cervical polyp, cervical carcinoma), vaginitis, local genital trauma.

Unexplained / Indeterminate (~30%): Marginal sinus rupture or localized retroplacental bleeding not meeting criteria for major abruption.

2. Placenta Previa

Placenta Previa occurs when the placenta implants partially or wholly over the lower uterine segment (in close proximity to or covering the internal cervical os).

Etiology & Risk Factors

Prior Cesarean Section: The single most potent risk factor. Risk increases exponentially with the number of prior uterine scars (1 prior CS: 0.65% risk; 4 prior CS: 10% risk). Strongly linked to Placenta Accreta Spectrum (PAS) .

Advanced maternal age ( > 35 years >35\text{ years} > 35 years ).

High multiparity.

Prior uterine curettage or myomectomy.

Multiple pregnancy (larger placental surface area).

Maternal cigarette smoking.

Anatomical Degrees / Types

Type Name Anatomical Relationship to Internal Cervical Os

Type I Low-Lying Placenta Placental lower margin is in lower uterine segment but does not reach internal os ( < 2 cm < 2\text{ cm} < 2 cm from os)

  • Type II Marginal Placenta Placenta reaches the margin of the internal os but does not cover it
  • Type III Partial / Incomplete Placenta covers internal os when closed, but not when dilated
  • Type IV Complete / Total Central Placenta completely covers the internal os even when fully dilated

Type II Anterior vs. Type II Posterior (Stallworthy's Sign): Type II Anterior is safe for trial of labor. Type II Posterior is known as the "Dangerous Placenta Previa." As the fetal head descends into the pelvic brim, it compresses the posterior low-lying placenta against the sacral promontory, compromising fetal umbilical blood flow and precipitating acute fetal distress or fetal demise.

Clinical Presentation

Classical Triad: Painless, Causeless, Recurrent, Bright Red vaginal bleeding.

Abdominal Examination: Uterus is soft, relaxed, non-tender . Fundal height corresponds to gestational age. Fetal parts are easily palpable. Malpresentations (breech, transverse lie, oblique lie) and a high, unengaged presenting part are frequently present.

Diagnostic Golden Rules

Gold Standard: Transvaginal Ultrasonography (TVS) is accurate, safe, and superior to transabdominal ultrasound for evaluating the exact distance between the placental edge and the internal os.

CRITICAL CONTRAINDICATION: Digital vaginal examination (Per Vaginam / PV exam) is STRICTLY CONTRAINDICATED in any woman presenting with APH until placenta previa has been definitively excluded by ultrasound! A digital exam can tear the placental attachment and provoke catastrophic, fatal hemorrhage.

Management Protocols

Macafee and Johnson Conservative Management:

Indications: Gestation < 37 weeks < 37\text{ weeks} < 37 weeks , bleeding mild or stopped, mother hemodynamically stable, fetus alive without distress.

Protocol: Strict bed rest, cross-matched blood on standby, administration of antenatal corticosteroids (Betamethasone 12 mg IM 2 doses 24 hours apart) if < 34 weeks < 34\text{ weeks} < 34 weeks for fetal lung maturity.

Definitive Delivery Indications: Active heavy bleeding, gestation ≥ 37 weeks \ge 37\text{ weeks} ≥ 37 weeks , labor, or fetal distress.

Mode of Delivery:

Vaginal Delivery Trial: Type I and Type II Anterior (if placental edge is > 2 cm > 2\text{ cm} > 2 cm from os).

Cesarean Section: Absolute indication for Type II Posterior, Type III, and Type IV placenta previa.

3. Abruptio Placentae (Placental Abruption)

Abruptio Placentae is the premature detachment of a normally implanted placenta from the uterine wall after 28 weeks of gestation and before the delivery of the fetus.

Risk Factors

Maternal Hypertensive Disorders: Pre-eclampsia, chronic hypertension (accounts for > 50 % > 50\% > 50% of severe cases; #1 risk factor).

Sudden uterine decompression (e.g., rapid drainage of polyhydramnios, delivery of first twin).

External abdominal trauma (motor vehicle accident, domestic violence).

Short umbilical cord.

Maternal cocaine abuse, tobacco smoking, thrombophilias.

Clinical Types

Revealed Abruption (80%): Blood escapes through the cervix and drains externally. Pain and dark blood present.

Concealed Abruption (20%): Blood accumulates behind the detached placenta (retroplacental hematoma) without external bleeding. Severe abdominal pain, uterine hypertonus, and maternal shock disproportionate to visible blood loss.

Mixed Abruption: Combination of revealed and concealed components.

Clinical Features & Pathology

Clinical Presentation: Painful, Dark Red vaginal bleeding accompanied by continuous severe abdominal or lower back pain.

Abdominal Examination: Uterus is woody hard, board-like rigid, extremely tender . Fundal height may increase progressively in concealed abruption. Fetal parts are difficult to palpate due to uterine hypertonus. Fetal heart rate is often absent (fetal demise in ~20–30%) or exhibits severe late decelerations.

Severe Complications

Couvelaire Uterus (Uteroplacental Apoplexy): Massive extravasation of blood into the uterine myometrium beneath the serosal perimetrium, extending into the broad ligaments. The uterus appears dark purplish/bluish mottled. It leads to severe myometrial atony and postpartum hemorrhage (PPH).

Disseminated Intravascular Coagulation (DIC): Release of placental tissue thromboplastin into maternal circulation activates extrinsic coagulation cascade. Characterized by low fibrinogen ( < 150 mg/dL < 150\text{ mg/dL} < 150 mg/dL ), low platelets, and elevated D-dimer.

Acute Kidney Injury (AKI): Caused by severe hypovolemic shock and acute tubular/cortical necrosis.

4. Differential Diagnosis: Placenta Previa vs. Abruptio Placentae

  • Clinical Parameter Placenta Previa Abruptio Placentae
  • Nature of Bleeding Painless, causeless, recurrent, bright red Painful, associated with trauma/HTN, dark red
  • Uterine Tone Soft, relaxed, normal tone Board-like rigid, woody hard, hypertonic
  • Uterine Tenderness Absent Markedly tender
  • Fetal Palpation Fetal parts easily felt; malpresentation common Fetal parts difficult to feel
  • Fetal Heart Sounds Usually normal and present Often absent or severe fetal distress
  • Hypertension Association Unrelated Strongly associated ( > 50 % > 50\% > 50% )
  • Coagulopathy (DIC) Rare Common (especially in concealed type)
  • 5. Vasa Previa

Vasa Previa occurs when fetal blood vessels run unprotected by Wharton's jelly or placental tissue through the fetal membranes across the internal cervical os, ahead of the presenting fetal part. It is commonly associated with velamentous cord insertion or a succenturiate placental lobe .

Diagnostic Triad & Test

Classic Triad: Rupture of membranes (spontaneous or artificial) → \rightarrow → Painless vaginal bleeding → \rightarrow → Rapid fetal bradycardia / asphyxia / death (because the bleeding is pure fetal blood).

Diagnostic Apt Test (NaOH Test): Distinguishes fetal hemoglobin ( H b F HbF H b F ) from maternal hemoglobin ( H b A HbA H b A ). Addition of 1 mL 1\text{ mL} 1 mL of 1 % 1\% 1% Sodium Hydroxide ( N a O H NaOH N a O H ) to 4 mL 4\text{ mL} 4 mL of blood solution:

Fetal Blood: Remains PINK (alkali-resistant H b F HbF H b F ).

Maternal Blood: Turns BROWN-YELLOW (alkali-labile H b A HbA H b A ).

Loading diagram... Clinical Differentiation & Management Pathway of Antepartum Haemorrhage